Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:INBSNASDAQ:NURONASDAQ:POAINASDAQ:TIVC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINBSIntelligent Bio Solutions$1.29-5.5%$1.49$1.00▼$3.00$8.75M4.63551,501 shs472,145 shsNURONeuroMetrix$4.55+4.4%$4.43$2.66▼$4.73$9.37M1.8215,372 shs35,522 shsPOAIPredictive Oncology$1.07-2.7%$1.13$0.55▼$3.06$9.56M1.32.32 million shs60,404 shsTIVCTivic Health Systems$4.32+7.7%$4.11$2.43▼$16.08$2.65M2.03647,021 shs108,373 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINBSIntelligent Bio Solutions+9.24%+13.33%+7.09%-45.38%-43.57%NURONeuroMetrix0.00%0.00%+4.12%+3.88%+0.22%POAIPredictive Oncology-1.79%+6.80%+10.01%-24.66%-34.13%TIVCTivic Health Systems-5.20%-8.03%-8.24%-66.30%-51.24%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINBSIntelligent Bio Solutions0.3156 of 5 stars0.03.00.00.01.60.00.6NURONeuroMetrix0.507 of 5 stars0.03.00.00.02.70.00.6POAIPredictive Oncology2.6336 of 5 stars3.05.00.00.02.70.01.3TIVCTivic Health Systems0.111 of 5 stars0.02.00.00.02.10.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINBSIntelligent Bio Solutions 0.00N/AN/AN/ANURONeuroMetrix 0.00N/AN/AN/APOAIPredictive Oncology 2.00Hold$3.00180.37% UpsideTIVCTivic Health Systems 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINBSIntelligent Bio Solutions$3.03M2.89N/AN/A$0.80 per share1.61NURONeuroMetrix$3.03M3.09N/AN/A$13.18 per share0.35POAIPredictive Oncology$1.62M5.89N/AN/A$2.04 per share0.52TIVCTivic Health Systems$780K3.40N/AN/A$2.44 per share1.77Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINBSIntelligent Bio Solutions-$10.16MN/A0.003.67N/A-323.79%-146.03%-83.62%N/ANURONeuroMetrix-$6.53M-$4.59N/A∞N/A-203.71%-42.56%-39.26%5/21/2025 (Estimated)POAIPredictive Oncology-$13.98M-$3.05N/AN/AN/A-1,012.32%-286.30%-122.11%N/ATIVCTivic Health Systems-$8.24MN/A0.00∞N/A-670.95%-201.30%-154.54%5/15/2025 (Estimated)Latest TIVC, POAI, NURO, and INBS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025POAIPredictive Oncology-$0.09-$0.32-$0.23-$0.34$1.50 millionN/A3/21/2025Q4 2024TIVCTivic Health Systems-$85.00-$19.68+$65.32N/A$1.43 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/ANURONeuroMetrixN/AN/AN/AN/AN/APOAIPredictive OncologyN/AN/AN/AN/AN/ATIVCTivic Health SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINBSIntelligent Bio SolutionsN/A0.920.76NURONeuroMetrixN/A13.8812.70POAIPredictive OncologyN/A1.201.06TIVCTivic Health SystemsN/A5.654.34Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINBSIntelligent Bio Solutions32.97%NURONeuroMetrix19.40%POAIPredictive Oncology9.04%TIVCTivic Health Systems4.25%Insider OwnershipCompanyInsider OwnershipINBSIntelligent Bio Solutions1.54%NURONeuroMetrix7.30%POAIPredictive Oncology3.44%TIVCTivic Health Systems0.31%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINBSIntelligent Bio Solutions106.81 million5.26 millionNot OptionableNURONeuroMetrix202.06 million1.90 millionNot OptionablePOAIPredictive Oncology308.93 million6.44 millionNot OptionableTIVCTivic Health Systems10613,0009.44 millionNot OptionableTIVC, POAI, NURO, and INBS HeadlinesRecent News About These CompaniesTivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA SubmissionMay 14 at 12:00 PM | finance.yahoo.comTivic adds new vagus nerve stim patentMay 13 at 4:19 PM | massdevice.comTivic Expands VNS Intellectual Property PortfolioMay 13 at 8:30 AM | businesswire.comTivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and WebcastMay 9, 2025 | businesswire.comTivic Health reports White House briefings, FDA meetings on product applicationsApril 23, 2025 | markets.businessinsider.comTivic Health Systems Stock Is On Fire Today: What's Going On?April 22, 2025 | benzinga.comTivic Health Systems Shares Rise on White House and FDA BriefingsApril 22, 2025 | marketwatch.comTivic Health Stock Doubles After Briefings To Senior Leadership At White House, FDA: But Retail Stays BearishApril 22, 2025 | msn.comTivic Health shares soar on defense application interestApril 22, 2025 | investing.comTivic Health exercises licensing option for EntolimodApril 17, 2025 | markets.businessinsider.comTivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of NeutropeniaApril 15, 2025 | businesswire.comTivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing RuleApril 10, 2025 | businesswire.comTivic Health Systems, Inc. (NASDAQ:TIVC) Q4 2024 Earnings Call TranscriptMarch 26, 2025 | msn.comTivic Health Systems’ Earnings Call Highlights Strategic ShiftMarch 24, 2025 | tipranks.comTivic Health Reports 2024 Results and Strategic GrowthMarch 22, 2025 | tipranks.comTivic Health targets FDA approval for Entolimod within 18 months, highlights transformation into biopharmaMarch 21, 2025 | msn.comTivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and GrowthMarch 21, 2025 | finance.yahoo.comTivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call TranscriptMarch 21, 2025 | seekingalpha.comTivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and WebcastMarch 13, 2025 | businesswire.comTivic Health Systems Inc trading halted, news pendingMarch 7, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTIVC, POAI, NURO, and INBS Company DescriptionsIntelligent Bio Solutions NASDAQ:INBS$1.28 -0.08 (-5.51%) As of 03:59 PM EasternIntelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.NeuroMetrix NASDAQ:NURO$4.55 +0.19 (+4.36%) Closing price 05/1/2025Extended Trading$4.55 0.00 (0.00%) As of 05/1/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.Predictive Oncology NASDAQ:POAI$1.07 -0.03 (-2.73%) As of 04:00 PM EasternPredictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.Tivic Health Systems NASDAQ:TIVC$4.32 +0.31 (+7.73%) As of 04:00 PM EasternTivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start AMD’s AI-Powered Stock Price Rally Just Shifted Gears Oklo Reaches Critical Mass, Atomic Upside Still Available Is Verizon a Buy? Q1 Results and Solid Dividend Make Bullish Case Carnival's Comeback: Is the Stock Set for a Profitable Journey? 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears U.S. Regulators Target CrowdStrike: Is It a Signal or Noise? Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
